Characterization of metabolic health in mouse models of fibrillin-1 perturbation

Tezin A. Walji, Sarah E. Turecamo, Antea J. DeMarsilis, Lynn Sakai, Robert P. Mecham, Clarissa S. Craft

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Mutations in the microfibrillar protein fibrillin-1 or the absence of its binding partner microfibril-associated glycoprotein (MAGP1) lead to increased TGFβ signaling due to an inability to sequester latent or active forms of TGFβ, respectively. Mouse models of excess TGFβ signaling display increased adiposity and predisposition to type-2 diabetes. It is therefore interesting that individuals with Marfan syndrome, a disease in which fibrillin-1 mutation leads to aberrant TGFβ signaling, typically present with extreme fat hypoplasia. The goal of this project was to characterize multiple fibrillin-1 mutant mouse strains to understand how fibrillin-1 contributes to metabolic health. The results of this study demonstrate that fibrillin-1 contributes little to lipid storage and metabolic homeostasis, which is in contrast to the obesity and metabolic changes associated with MAGP1 deficiency. MAGP1 but not fibrillin-1 mutant mice had elevated TGFβ signaling in their adipose tissue, which is consistent with the difference in obesity phenotypes. However, fibrillin-1 mutant strains and MAGP1-deficient mice all exhibit increased bone length and reduced bone mineralization which are characteristic of Marfan syndrome. Our findings suggest that Marfan-associated adipocyte hypoplasia is likely not due to microfibril-associated changes in adipose tissue, and provide evidence that MAGP1 may function independently of fibrillin in some tissues.

Original languageEnglish (US)
Pages (from-to)63-76
Number of pages14
JournalMatrix Biology
Volume55
DOIs
StatePublished - Sep 1 2016

Fingerprint

Health
Marfan Syndrome
Adipose Tissue
Mutant Strains Mice
Obesity
Microfibrils
Physiologic Calcification
Mutation
Adiposity
Fibrillin-1
Adipocytes
Type 2 Diabetes Mellitus
Homeostasis
Fats
Phenotype
Lipids
Bone and Bones
microfibrillar protein

Keywords

  • Adipose tissue
  • Diabetes
  • Fibrillin
  • MAGP
  • Microfibril
  • TGFβ

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Walji, T. A., Turecamo, S. E., DeMarsilis, A. J., Sakai, L., Mecham, R. P., & Craft, C. S. (2016). Characterization of metabolic health in mouse models of fibrillin-1 perturbation. Matrix Biology, 55, 63-76. https://doi.org/10.1016/j.matbio.2016.02.006

Characterization of metabolic health in mouse models of fibrillin-1 perturbation. / Walji, Tezin A.; Turecamo, Sarah E.; DeMarsilis, Antea J.; Sakai, Lynn; Mecham, Robert P.; Craft, Clarissa S.

In: Matrix Biology, Vol. 55, 01.09.2016, p. 63-76.

Research output: Contribution to journalArticle

Walji, Tezin A. ; Turecamo, Sarah E. ; DeMarsilis, Antea J. ; Sakai, Lynn ; Mecham, Robert P. ; Craft, Clarissa S. / Characterization of metabolic health in mouse models of fibrillin-1 perturbation. In: Matrix Biology. 2016 ; Vol. 55. pp. 63-76.
@article{6b47245ae5ad451097e5464699c52d91,
title = "Characterization of metabolic health in mouse models of fibrillin-1 perturbation",
abstract = "Mutations in the microfibrillar protein fibrillin-1 or the absence of its binding partner microfibril-associated glycoprotein (MAGP1) lead to increased TGFβ signaling due to an inability to sequester latent or active forms of TGFβ, respectively. Mouse models of excess TGFβ signaling display increased adiposity and predisposition to type-2 diabetes. It is therefore interesting that individuals with Marfan syndrome, a disease in which fibrillin-1 mutation leads to aberrant TGFβ signaling, typically present with extreme fat hypoplasia. The goal of this project was to characterize multiple fibrillin-1 mutant mouse strains to understand how fibrillin-1 contributes to metabolic health. The results of this study demonstrate that fibrillin-1 contributes little to lipid storage and metabolic homeostasis, which is in contrast to the obesity and metabolic changes associated with MAGP1 deficiency. MAGP1 but not fibrillin-1 mutant mice had elevated TGFβ signaling in their adipose tissue, which is consistent with the difference in obesity phenotypes. However, fibrillin-1 mutant strains and MAGP1-deficient mice all exhibit increased bone length and reduced bone mineralization which are characteristic of Marfan syndrome. Our findings suggest that Marfan-associated adipocyte hypoplasia is likely not due to microfibril-associated changes in adipose tissue, and provide evidence that MAGP1 may function independently of fibrillin in some tissues.",
keywords = "Adipose tissue, Diabetes, Fibrillin, MAGP, Microfibril, TGFβ",
author = "Walji, {Tezin A.} and Turecamo, {Sarah E.} and DeMarsilis, {Antea J.} and Lynn Sakai and Mecham, {Robert P.} and Craft, {Clarissa S.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.matbio.2016.02.006",
language = "English (US)",
volume = "55",
pages = "63--76",
journal = "Matrix Biology",
issn = "0945-053X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Characterization of metabolic health in mouse models of fibrillin-1 perturbation

AU - Walji, Tezin A.

AU - Turecamo, Sarah E.

AU - DeMarsilis, Antea J.

AU - Sakai, Lynn

AU - Mecham, Robert P.

AU - Craft, Clarissa S.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Mutations in the microfibrillar protein fibrillin-1 or the absence of its binding partner microfibril-associated glycoprotein (MAGP1) lead to increased TGFβ signaling due to an inability to sequester latent or active forms of TGFβ, respectively. Mouse models of excess TGFβ signaling display increased adiposity and predisposition to type-2 diabetes. It is therefore interesting that individuals with Marfan syndrome, a disease in which fibrillin-1 mutation leads to aberrant TGFβ signaling, typically present with extreme fat hypoplasia. The goal of this project was to characterize multiple fibrillin-1 mutant mouse strains to understand how fibrillin-1 contributes to metabolic health. The results of this study demonstrate that fibrillin-1 contributes little to lipid storage and metabolic homeostasis, which is in contrast to the obesity and metabolic changes associated with MAGP1 deficiency. MAGP1 but not fibrillin-1 mutant mice had elevated TGFβ signaling in their adipose tissue, which is consistent with the difference in obesity phenotypes. However, fibrillin-1 mutant strains and MAGP1-deficient mice all exhibit increased bone length and reduced bone mineralization which are characteristic of Marfan syndrome. Our findings suggest that Marfan-associated adipocyte hypoplasia is likely not due to microfibril-associated changes in adipose tissue, and provide evidence that MAGP1 may function independently of fibrillin in some tissues.

AB - Mutations in the microfibrillar protein fibrillin-1 or the absence of its binding partner microfibril-associated glycoprotein (MAGP1) lead to increased TGFβ signaling due to an inability to sequester latent or active forms of TGFβ, respectively. Mouse models of excess TGFβ signaling display increased adiposity and predisposition to type-2 diabetes. It is therefore interesting that individuals with Marfan syndrome, a disease in which fibrillin-1 mutation leads to aberrant TGFβ signaling, typically present with extreme fat hypoplasia. The goal of this project was to characterize multiple fibrillin-1 mutant mouse strains to understand how fibrillin-1 contributes to metabolic health. The results of this study demonstrate that fibrillin-1 contributes little to lipid storage and metabolic homeostasis, which is in contrast to the obesity and metabolic changes associated with MAGP1 deficiency. MAGP1 but not fibrillin-1 mutant mice had elevated TGFβ signaling in their adipose tissue, which is consistent with the difference in obesity phenotypes. However, fibrillin-1 mutant strains and MAGP1-deficient mice all exhibit increased bone length and reduced bone mineralization which are characteristic of Marfan syndrome. Our findings suggest that Marfan-associated adipocyte hypoplasia is likely not due to microfibril-associated changes in adipose tissue, and provide evidence that MAGP1 may function independently of fibrillin in some tissues.

KW - Adipose tissue

KW - Diabetes

KW - Fibrillin

KW - MAGP

KW - Microfibril

KW - TGFβ

UR - http://www.scopus.com/inward/record.url?scp=84959305182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959305182&partnerID=8YFLogxK

U2 - 10.1016/j.matbio.2016.02.006

DO - 10.1016/j.matbio.2016.02.006

M3 - Article

VL - 55

SP - 63

EP - 76

JO - Matrix Biology

JF - Matrix Biology

SN - 0945-053X

ER -